TARGET AUDIENCE:
This educational activity is intended for medical oncologists and other members of the health care team who care for patients with hepatocellular carcinoma (HCC).

PROGRAM OVERVIEW:
This activity provides the latest clinical information to increase clinicians’ knowledge and improve their competence in providing the most accurate recommendations for treatment as members of the multidisciplinary hepatocellular carcinoma (HCC) cancer treatment team.

Upon completion of the activity, participants should be able to:

• Apply strategies for early and accurate diagnosis of HCC stages
• Summarize mechanisms of action and clinical profiles of new and emerging immuno-oncology (IO) agents (mono and combo) for each stage of HCC
• Analyze data on IO therapy with liver-directed therapy procedures to identify appropriate patients
• Describe the role of HCC care team members and explain techniques to increase communication and collaboration

FACULTY
Adam Burgoyne, MD, PhD
Chair of the Steering Committee
Associate Clinical Professor
Department of Medicine
Division of Hematology/Oncology
University of California, San Diego
San Diego, California

Stacey Stein, MD
Associate Professor of Internal Medicine
Assistant Medical Director, Clinical Trials Office
Yale Medicine
New Haven, Connecticut

PLANNING COMMITTEE
Adam Burgoyne, MD, PhD
Chair of the Steering Committee
Associate Clinical Professor
Department of Medicine
Division of Hematology/Oncology
University of California, San Diego
San Diego, California

Amit Singal, MD
Medical Director of the Liver Tumor Program
Clinical Chief of Hepatology
Professor of Internal Medicine
UT Southwestern Medical Center
Dallas, Texas

Cindi Cantril, MPH, RN, OCN, CBCN
Cancer Resources Recovery
Geyersville, California

Isabel Newton, MD, PhD
Department of Radiology
Assistant Professor of Radiology
University of California, San Diego
San Diego, California

Rony Avritscher, MD, FSIR
Department of Interventional Radiology
Professor of Interventional Radiology
MD Anderson Cancer Center
Houston, Texas

Sarah Manes, MS, CCLS
Liver Cancers Program Director
Global Liver Institute
Washington, DC

Stacey Stein, MD
Associate Professor of Internal Medicine
Assistant Medical Director, Clinical Trials Office
Yale Medicine
New Haven, Connecticut

Patrick Harty, PhD
Medical Director
The France Foundation

This activity is jointly provided by The France Foundation and Association of Community Cancer Centers.

ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by The France Foundation and Association of Community Cancer Centers. The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION

The France Foundation designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES

The France Foundation designates this activity for 1.0 contact hours.

All other healthcare professionals completing this course will be issued a statement of participation.

DISCLOSURE POLICY

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, The France Foundation (TFF) and ACCC require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial entity. TFF and ACCC resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, TFF and ACCC seek to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF and ACCC are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Planning committee members, faculty, reviewers, and activity staff have disclosed the following relevant financial relationships. All relevant financial relationships listed have been mitigated.

TFF and ACCC require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF and ACCC do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

This activity is supported by an educational grant from AstraZeneca.

The France Foundation and Association of Community Cancer Centers present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and Association of Community Cancer Centers and the commercial supporter(s) assume no liability for the information herein.

Copyright © 2023 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

• The materials are to be used solely for personal, noncommercial, informational, and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
• Materials may not be published, uploaded, posted, or transmitted (other than as set forth herein) without The France Foundation's prior written permission